Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 225,887 | 114,428 | -72,003 | -264,586 | -337,682 |
| Depreciation Amortization | 11,861 | 5,850 | 20,859 | 14,702 | 9,550 |
| Income taxes - deferred | 74,809 | 43,220 | -250,061 | N/A | N/A |
| Accounts receivable | -46,989 | -27,391 | -92,207 | -67,112 | -66,278 |
| Accounts payable and accrued liabilities | -5,663 | -7,544 | 6,144 | -4,820 | -5,867 |
| Other Working Capital | -77,318 | -48,186 | 391,386 | -108,373 | -83,254 |
| Other Operating Activity | 38,107 | 17,829 | 230,489 | 564,883 | 563,915 |
| Operating Cash Flow | $220,694 | $98,206 | $234,607 | $134,694 | $80,384 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -214,708 | -147,153 | -190,229 | -195,753 | -188,230 |
| PPE Investments | -18,197 | -5,378 | -161,609 | -140,681 | -7,813 |
| Net Acquisitions | N/A | N/A | -375,507 | -375,507 | -375,507 |
| Investing Cash Flow | $-232,905 | $-152,531 | $-727,345 | $-711,941 | $-571,550 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -68 | N/A | -1,715 | -1,710 | -1,760 |
| Common Stock Issued | 39,760 | 10,917 | 83,806 | 69,988 | 49,821 |
| Financing Cash Flow | $39,692 | $10,917 | $82,091 | $68,278 | $48,061 |
| Exchange Rate Effect | 4,363 | 4,274 | -11,565 | -4,645 | -4,471 |
| Beginning Cash Position | 194,719 | 194,719 | 616,931 | 616,931 | 616,931 |
| End Cash Position | 226,563 | 155,585 | 194,719 | 103,317 | 169,355 |
| Net Cash Flow | $31,844 | $-39,134 | $-422,212 | $-513,614 | $-447,576 |
| Free Cash Flow | |||||
| Operating Cash Flow | 220,694 | 98,206 | 234,607 | 134,694 | 80,384 |
| Capital Expenditure | -18,197 | -5,378 | -161,609 | -140,681 | -7,813 |
| Free Cash Flow | 202,497 | 92,828 | 72,998 | -5,987 | 72,571 |